Early AF Rhythm-Control Advantage Climbs With Comorbidity Burden
Sicker patients in the EAST-AFNET4 trial showed a pronounced survival advantage from early rhythm control, compared with a rate-control-first approach, while those with fewer comorbidities missed out.
Source: medscape.com